← Back to Search

Media Literacy Program for Preventing Tobacco Use in Adolescents

N/A
Waitlist Available
Led By Jaime Sidani, PhD MPH
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

This trial will study if a web-based media literacy program can help prevent tobacco use in high school students.

Who is the study for?
This trial is for 9th or 10th grade students enrolled at certain Pittsburgh-area high schools. It's designed to see if a web-based program can help prevent tobacco use by teaching about media influence. Students who can't read the surveys used in the study are not eligible to participate.Check my eligibility
What is being tested?
The study is testing 'AD IT UP', a new online program that teaches kids how to understand and question advertising related to tobacco products, against the usual health education curriculum they receive in school.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, there are no direct physical side effects expected from participating. However, participants may experience changes in their perception of media.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of eligible 9th or 10th grade students recruited to participate in the study
Percentage of participants indicating moderate to high acceptability of the AD IT UP program
Percentage of participants retained through the final data collection
Secondary outcome measures
Change in tobacco-related media literacy
Changes in attitudes toward tobacco products
Changes in intention to use tobacco products
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Usual Health Education Curriculum plus InterventionExperimental Treatment2 Interventions
Students will receive the school's usual health education curriculum. Students will also receive the intervention. Delivery of the intervention (i.e., timing, frequency) will be determined by discussing the results of the Aim 1 focus groups with teachers and administrators.
Group II: Usual Health Education CurriculumActive Control1 Intervention
Students will receive the school's usual health education curriculum.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
AD IT UP media literacy intervention
2022
N/A
~340
Usual health education curriculum
2022
N/A
~340

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,737 Previous Clinical Trials
16,339,110 Total Patients Enrolled
1 Trials studying Tobacco Use
339 Patients Enrolled for Tobacco Use
American Heart AssociationOTHER
336 Previous Clinical Trials
4,934,997 Total Patients Enrolled
Jaime Sidani, PhD MPHPrincipal InvestigatorUniversity of Pittsburgh
1 Previous Clinical Trials
339 Total Patients Enrolled
1 Trials studying Tobacco Use
339 Patients Enrolled for Tobacco Use

Media Library

AD IT UP media literacy intervention Clinical Trial Eligibility Overview. Trial Name: NCT05120466 — N/A
Tobacco Use Research Study Groups: Usual Health Education Curriculum, Usual Health Education Curriculum plus Intervention
Tobacco Use Clinical Trial 2023: AD IT UP media literacy intervention Highlights & Side Effects. Trial Name: NCT05120466 — N/A
AD IT UP media literacy intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05120466 — N/A
~45 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top